US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
EP1877054A2
(en)
*
|
2005-03-30 |
2008-01-16 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
EP3369738B1
(en)
|
2005-11-18 |
2020-05-20 |
Cornell Research Foundation, Inc. |
Method for making nicotinoyl ribosides and nicotinamide beta-riboside
|
US9874501B2
(en)
|
2006-11-24 |
2018-01-23 |
Curiox Biosystems Pte Ltd. |
Use of chemically patterned substrate for liquid handling, chemical and biological reactions
|
WO2008063135A1
(en)
|
2006-11-24 |
2008-05-29 |
Agency For Science, Technology And Research |
Apparatus for processing a sample in a liquid droplet and method of using the same
|
WO2013114217A1
(en)
|
2012-02-05 |
2013-08-08 |
Curiox Biosystems Pte Ltd. |
Array plates and methods for making and using same
|
US10725020B2
(en)
*
|
2007-11-14 |
2020-07-28 |
Curiox Biosystems Pte Ltd. |
High throughput miniaturized assay system and methods
|
US20120156134A1
(en)
|
2007-12-20 |
2012-06-21 |
Shayne Squires |
Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
|
JP2011526900A
(ja)
*
|
2008-06-30 |
2011-10-20 |
イーエルシー マネージメント エルエルシー |
イソニコチンアミドを含む外用組成物
|
AU2010203356B2
(en)
|
2009-01-09 |
2015-11-26 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
US8362277B2
(en)
|
2009-01-09 |
2013-01-29 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
US9162980B2
(en)
|
2009-01-09 |
2015-10-20 |
Board Of Regents Of The University Of Texas System |
Anti-depression compounds
|
US9603862B2
(en)
|
2009-12-14 |
2017-03-28 |
Cornell University |
Activation and activators of SIRT5
|
CA2804161A1
(en)
|
2010-07-07 |
2012-01-12 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
US9878328B2
(en)
|
2010-07-23 |
2018-01-30 |
Curiox Biosystems Pte Ltd. |
Apparatus and method for multiple reactions in small volumes
|
CN102000079B
(zh)
*
|
2010-09-30 |
2012-05-30 |
中国人民解放军第二军医大学 |
尼克酰胺单核苷酸磷酸核糖转移酶抑制剂的应用
|
US20140065099A1
(en)
|
2011-02-15 |
2014-03-06 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Methods of Treating Mitochondrial Dysfunction
|
WO2012177927A1
(en)
|
2011-06-21 |
2012-12-27 |
Mayo Foundation For Medical Education And Research |
Transgenic animals capable of being induced to delete senescent cells
|
US20120328526A1
(en)
*
|
2011-06-27 |
2012-12-27 |
University Of Maryland, Baltimore |
Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
|
AU2012352177A1
(en)
|
2011-12-13 |
2014-07-10 |
Buck Institute For Research On Aging |
Methods for improving medical therapies
|
US20150064137A1
(en)
|
2012-04-17 |
2015-03-05 |
Kythera Biopharmaceuticals, Inc. |
Use of engineered viruses to specifically kill senescent cells
|
US9901080B2
(en)
|
2012-08-23 |
2018-02-27 |
Buck Institute For Research On Aging |
Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
|
US9901081B2
(en)
|
2012-08-23 |
2018-02-27 |
Buck Institute For Research On Aging |
Transgenic mouse for determining the role of senescent cells in cancer
|
CN102876759A
(zh)
*
|
2012-10-29 |
2013-01-16 |
尚科生物医药(上海)有限公司 |
尼克酰胺腺嘌呤二核苷酸的制备方法
|
CN103233051B
(zh)
*
|
2012-12-19 |
2016-01-27 |
浙江嘉华化工有限公司 |
一种化学生物合成法规模化制备尼克酰胺腺嘌呤二核苷酸的方法
|
US9557318B2
(en)
|
2013-07-09 |
2017-01-31 |
Curiox Biosystems Pte Ltd. |
Array plates for washing samples
|
DE202013006354U1
(de)
*
|
2013-07-15 |
2014-10-20 |
Marianne Brøndlund |
Stoffgemisch zur Behandlung von Koagulopathien
|
GB201313465D0
(en)
*
|
2013-07-29 |
2013-09-11 |
Queens University Of The Belfast |
Methods of preparing nicotinamide riboside and derivatives thereof
|
KR20220098049A
(ko)
*
|
2013-10-30 |
2022-07-08 |
크로마덱스 아이엔씨. |
피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
|
WO2015070237A1
(en)
*
|
2013-11-11 |
2015-05-14 |
Board Of Regents Of The University Of Texas System |
Neuroprotective chemicals and methods for identifying and using same
|
US9902713B2
(en)
|
2013-11-11 |
2018-02-27 |
Board Of Regents Of The University Of Texas System |
Neuroprotective compounds and use thereof
|
EP3068364B1
(en)
*
|
2013-11-14 |
2021-11-03 |
Metro Biotech NSW Pty Ltd |
Nad+ precursor selected from nmn, naad, namn, or a pharmaceutically acceptable salt thereof, for use in treating a side effect of chemotherapy and/or radiotherapy in a subject
|
MX2016016071A
(es)
|
2014-06-06 |
2017-07-11 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Analogos de ribosido de nicotinamida y composiciones farmaceuticas y usos de los mismos.
|
CA2956163C
(en)
|
2014-07-24 |
2023-01-10 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
EP2979706A1
(en)
*
|
2014-07-30 |
2016-02-03 |
Fundación Centro Nacional De Investigaciones Oncológicas Carlos III |
Methods for treating liver or pancreatic cancer
|
CN104352513B
(zh)
*
|
2014-11-14 |
2017-04-05 |
邦泰生物工程(深圳)有限公司 |
Nadh或盐在制备治疗苯丙酮尿症药物或保健品的应用
|
US10525070B2
(en)
|
2015-02-10 |
2020-01-07 |
Duke University |
Method of treating heart failure
|
CN104622886A
(zh)
*
|
2015-03-05 |
2015-05-20 |
中国人民解放军第二军医大学 |
烟酰胺核糖在制备治疗非酒精性脂肪性肝炎的药物中的应用
|
KR102629310B1
(ko)
|
2015-03-09 |
2024-01-24 |
더블유.알. 그레이스 앤드 캄파니-콘. |
니코틴아미드 리보사이드의 결정 형태
|
CN104771330A
(zh)
*
|
2015-03-16 |
2015-07-15 |
邦泰生物工程(深圳)有限公司 |
一种含烟酰胺单核苷酸抗衰老美容护肤品组合物
|
KR102426320B1
(ko)
|
2015-03-16 |
2022-07-29 |
크로마덱스 아이엔씨. |
니코틴산 리보사이드 또는 니코틴아미드 리보사이드 조성물, 이의 환원 유도체, 및 이의 용도
|
CN108025187A
(zh)
|
2015-04-28 |
2018-05-11 |
新南创新私人有限公司 |
靶向nad+以治疗化学疗法和放射疗法引发的认知损害、神经病变和不活动
|
EP3288529A1
(en)
|
2015-05-01 |
2018-03-07 |
The Procter and Gamble Company |
Method of improving the appearance of skin and compositions therefor using nicotinamide riboside
|
JP2018515485A
(ja)
|
2015-05-01 |
2018-06-14 |
ザ プロクター アンド ギャンブル カンパニー |
皮膚の外観を改善する方法及びニコチンアミドリボシドを使用したそのための組成物
|
WO2016178949A1
(en)
*
|
2015-05-01 |
2016-11-10 |
The Procter & Gamble Company |
Method of improving skin health and compositions therefor
|
US10123985B2
(en)
|
2015-06-08 |
2018-11-13 |
Whitehead Institute For Biomedical Research |
Therapeutic strategies for treating mitochondrial disorders
|
CA2989115C
(en)
|
2015-06-10 |
2024-01-02 |
Elysium Health, Inc. |
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
|
US10545139B2
(en)
|
2015-06-16 |
2020-01-28 |
Curiox Biosystems Pte Ltd. |
Methods and devices for performing biological assays using magnetic components
|
WO2017004100A1
(en)
|
2015-06-29 |
2017-01-05 |
The Procter & Gamble Company |
Encapsulated particles comprising nicotinamide riboside
|
WO2017004101A1
(en)
|
2015-06-29 |
2017-01-05 |
The Procter & Gamble Company |
Skin care compositions comprising particles with nicotinamide riboside and methods of using the same
|
WO2017004102A1
(en)
|
2015-06-29 |
2017-01-05 |
The Procter & Gamble Company |
Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
|
EP3322419A4
(en)
*
|
2015-07-15 |
2018-08-01 |
Cornell University |
Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
|
WO2017024255A1
(en)
|
2015-08-05 |
2017-02-09 |
Metrobiotech, Llc |
Nicotinamide mononucleotide derivatives and their uses
|
IL299824B2
(en)
*
|
2015-10-07 |
2024-02-01 |
Huizenga Joel |
Resetting biological pathways for protection against human aging and repair of resulting degeneration
|
JP7242014B2
(ja)
|
2015-10-29 |
2023-03-20 |
エルジー ハウスホールド アンド ヘルスケア リミテッド |
新規な閉塞性組成物
|
WO2017079195A1
(en)
*
|
2015-11-02 |
2017-05-11 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
CN106470687A
(zh)
*
|
2015-12-11 |
2017-03-01 |
邦泰生物工程(深圳)有限公司 |
烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的保健品中的应用及其保健品
|
US20170165282A1
(en)
*
|
2015-12-11 |
2017-06-15 |
Bontac Bio-Engineering (Shenzhen) Co., Ltd. |
Use of beta-nicotinamide mononucleotide in preparation of drugs for preventing and treating arteriosclerosis and cardio-cerebrovascular diseases, and drugs containing the same
|
AU2016375177B2
(en)
*
|
2015-12-24 |
2022-09-01 |
Amazentis Sa |
Compositions comprising nicotinamide riboside and a urolithin
|
WO2017123512A1
(en)
|
2016-01-11 |
2017-07-20 |
The Procter & Gamble Company |
Method of treating a skin condition and compositions therefor
|
WO2017147058A1
(en)
*
|
2016-02-26 |
2017-08-31 |
Beth Israel Deaconess Medical Center, Inc. |
Niacinamide (nam) in ischemic tissue injury
|
CN108884483A
(zh)
*
|
2016-03-16 |
2018-11-23 |
帝斯曼知识产权资产管理有限公司 |
烟酸核糖苷的微生物生产
|
WO2017161165A1
(en)
*
|
2016-03-16 |
2017-09-21 |
ChromaDex Inc. |
B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
|
WO2017158132A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Dsm Ip Assets B.V. |
Microbial production of nicotinic acid riboside
|
JP7049683B2
(ja)
*
|
2016-04-04 |
2022-04-07 |
シノピア バイオサイエンシーズ,インク. |
トラピジルを使用する錐体外路症候群の処置
|
EP3442527A4
(en)
*
|
2016-04-14 |
2019-12-18 |
Chromadex Inc. |
USE OF NICOTINAMID RIBOSIDE, NICOTINIC ACID RIBOSIDE, NICOTINAMIDE MONONUCLEOTIDE AND DERIVATIVES OF A NICOTINOYL COMPOUND IN BABY FOOD
|
NZ747693A
(en)
*
|
2016-04-20 |
2023-07-28 |
Chromadex Inc |
Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors
|
WO2017218580A1
(en)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Synthetic methods for the preparation of nicotinamide riboside and related compounds
|
GB2553001A
(en)
*
|
2016-08-19 |
2018-02-21 |
The Queen's Univ Of Belfast |
Lactone intermediates of nicotinamide riboside and nicotinate riboside
|
US9975915B1
(en)
*
|
2016-11-11 |
2018-05-22 |
The Queen's University Of Belfast |
Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
EP3554285A4
(en)
|
2016-11-29 |
2021-01-20 |
University of Iowa Research Foundation |
USE OF NAD PRECURSORS TO IMPROVE MATERNAL HEALTH AND / OR DESCENDANT HEALTH
|
WO2018129039A1
(en)
|
2017-01-04 |
2018-07-12 |
President And Fellows Of Harvard College |
Modulating nudix homology domain (nhd) with nicotinamide mononucleotide analogs and derivatives of same
|
EP3568488A4
(en)
*
|
2017-01-13 |
2020-09-23 |
The Regents of The University of Colorado, A Body Corporate |
METHOD OF TREATMENT OF HYPERTENSION AND ARTERIAL STIFFNESS
|
US10376528B2
(en)
|
2017-03-10 |
2019-08-13 |
Tecton Group, Llc |
Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
|
WO2018185554A1
(en)
|
2017-04-05 |
2018-10-11 |
Curiox Biosystems Pte Ltd. |
Methods, devices, and apparatus for washing samples on array plates
|
DK3606929T3
(da)
|
2017-04-05 |
2021-08-23 |
Univ Cornell |
Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme
|
SG11201912267SA
(en)
*
|
2017-06-19 |
2020-01-30 |
Gangadhara Ganapati |
Nicotinamide riboside derivatives and their uses
|
WO2018237218A1
(en)
|
2017-06-23 |
2018-12-27 |
The Procter & Gamble Company |
COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
|
CA3068728A1
(en)
*
|
2017-06-30 |
2019-01-03 |
Elysium Health, Inc. |
Methods of synthesizing nicotinamide riboside
|
CN107536844A
(zh)
*
|
2017-06-30 |
2018-01-05 |
上海风劲生物医药科技有限公司 |
烟酰胺单核苷酸在制备预防或治疗rtPA血管并发症的药物中的应用
|
WO2019122084A1
(en)
|
2017-12-22 |
2019-06-27 |
Stemtek Therapeutics, S.L. |
Process for the preparation of nicotinamide riboside chloride derivatives
|
WO2019126482A1
(en)
|
2017-12-22 |
2019-06-27 |
Elysium Health, Inc. |
Crystalline forms of nicotinamide riboside chloride
|
JP2021524863A
(ja)
*
|
2018-05-15 |
2021-09-16 |
ジャンプスタート ファーティリティ ピーティーワイ リミテッド |
抗加齢剤としてのニコチン酸モノヌクレオチドの無機塩
|
CA3102288A1
(en)
|
2018-07-03 |
2020-01-09 |
The Procter & Gamble Company |
Method of treating a skin condition
|
CN108949677B
(zh)
*
|
2018-07-05 |
2021-11-30 |
浙江大学 |
地黄苷c和丹酚酸a在促进体外培养骨髓间充质干细胞增殖和抑制复制性衰老中的应用
|
CN109053838A
(zh)
*
|
2018-07-26 |
2018-12-21 |
四川大学 |
制备β-烟酰胺单核苷酸或β-烟酰胺核糖的方法
|
JP2022501331A
(ja)
|
2018-09-27 |
2022-01-06 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
少なくとも1つのグリシン又はその誘導体と、少なくとも1つのn−アセチルシステイン又はその誘導体と、少なくとも1つのニコチンアミドリボシド又はnad+前駆体と、を使用する組成物及び方法
|
WO2020072497A1
(en)
*
|
2018-10-01 |
2020-04-09 |
Cornell University |
Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
|
US11833167B2
(en)
|
2018-12-17 |
2023-12-05 |
Mitopower Llc |
Nicotinyl riboside compounds and their uses
|
WO2020191359A1
(en)
*
|
2019-03-21 |
2020-09-24 |
Fred Hutchinson Cancer Research Center |
Cancer combination therapies utilizing a nicotinamide phosphoribosyltransferase inhibitor in combination with a nicotinamide adenine dinucleotide salvage pathway precursor
|
KR20220039747A
(ko)
|
2019-07-19 |
2022-03-29 |
바이오신스 아게 |
니코틴아미드 리보푸라노사이드 염의 제조 방법, 니코틴아미드 리보푸라노사이드 염, 및 이의 용도
|
CN114555619A
(zh)
*
|
2019-08-14 |
2022-05-27 |
麦德龙国际生物科技有限责任公司 |
用于烟酰胺腺嘌呤二核苷酸的差分调节的化合物和组合物
|
KR102315139B1
(ko)
*
|
2019-12-17 |
2021-10-20 |
주식회사 휴메딕스 |
지방아민 컨쥬게이션된 니코틴아미드 리보사이드 유도체
|
CN111153953A
(zh)
*
|
2020-01-07 |
2020-05-15 |
杭州洁汉化工有限公司 |
一种烟酰胺核糖氯化物的高效合成方法
|
CN111253448B
(zh)
*
|
2020-03-04 |
2021-09-21 |
上海昶法新材料有限公司 |
一种β-烟酰胺单核苷酸的制备方法和纯化方法
|
WO2021198399A1
(en)
|
2020-04-01 |
2021-10-07 |
Société des Produits Nestlé S.A. |
Compositions and methods containing n-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions
|
US10959933B1
(en)
|
2020-06-01 |
2021-03-30 |
The Procter & Gamble Company |
Low pH skin care composition and methods of using the same
|
CN115843238A
(zh)
|
2020-06-01 |
2023-03-24 |
宝洁公司 |
改善维生素b3化合物渗透到皮肤中的方法
|
CN111632049A
(zh)
*
|
2020-06-09 |
2020-09-08 |
西北农林科技大学 |
一种通过综合矫正细胞活性氧簇代谢紊乱以缓解睾丸衰老损伤的复合配方
|
CN111763235A
(zh)
*
|
2020-06-29 |
2020-10-13 |
上海舒泽生物科技研究所 |
一种烟酰胺核糖的合成方法
|
CN111973614A
(zh)
*
|
2020-07-28 |
2020-11-24 |
南华大学 |
烟酰胺单核苷酸在制备预防、改善和/或治疗囊卵巢综合症的药物中的应用
|
WO2022047182A1
(en)
*
|
2020-08-28 |
2022-03-03 |
University Of Washington |
High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
|
CN116528865A
(zh)
|
2020-11-18 |
2023-08-01 |
雀巢产品有限公司 |
用于细胞能量的使用橄榄苦苷和烟酰胺核糖核苷的组合的组合物和方法
|
CN112851730B
(zh)
*
|
2021-01-08 |
2023-02-21 |
厦门瑞林药业有限公司 |
一种nmn中间体nr氯化物合成方法
|
WO2022233923A1
(en)
|
2021-05-04 |
2022-11-10 |
Bohan & Co As. |
A process for synthesis of nicotinamide riboside chloride (nrcl)
|
WO2023147161A2
(en)
*
|
2022-01-31 |
2023-08-03 |
New Frontier Bio, Inc. |
Nicotinate and nicotinamide riboside-based compounds and derivatives thereof
|
WO2023150072A1
(en)
|
2022-02-01 |
2023-08-10 |
Sinclair David A |
Compositions and methods for the preservation of plant matter
|